logo

For the Inventor, By the Inventor

Budapest, Hungary

Istvan Laszlovszky

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 3 CIPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Richter Gedeon Vegyeszeti Gyar Rt. Active years: 1987-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Istvan Laszlovszky. Retrieved from https://idiyas.com/inventor/istvan-laszlovszky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 100.0

 

Average Co-Inventor Count = 11.5

ph-index = 6

Forward Citations = 80(Granted Patents)


Company Filing History:

goldMedal17 out of 346 
 
Richter Gedeon Vegyeszeti Gyar Rt
 patents

Years Active: 1987-2010

Loading Chart...
Loading Chart...
Areas of Expertise:
Dopaminergic Activity
Piperazine Derivatives
Spiro Compounds
Pharmaceutical Compositions
Heterocyclic Compounds
Antihypoxic Activity
Neuroleptic Action
Cyclohexane Derivatives
Azaspiro Compounds
Carbamoyl Derivatives
Alkylamino-Furanon
Phenylpiperazine
17 patents (USPTO):Explore Patents
1. 7737142 - (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists (2010-06-15),
2. 6103724 - 2-methoxyphenylpiperazine derivatives (2000-08-15),
3. 5157038 - 2-oxo-1-oxa-8 azaspiro[4,5]decane derivatives, pharmaceutical (1992-10-20),
4. 5132309 - 2-oxo-3,8-diazaspiro(4,5)decane derivatives, pharmaceutical compositions (1992-07-21),
5. 5132303 - 4-methylene-2-oxo-8-azaspiro[4,5]decane derivatives, pharmaceutical (1992-07-21),
6. 5118693 - 4,4-disubstituted piperidine derivatives, pharmaceutical compositions (1992-06-02),
7. 5118687 - 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical (1992-06-02),
8. 5096902 - Heterocyclic compounds containing nitrogen and sulfur, pharmaceutical (1992-03-17),
9. 4874765 - 1,4-Disubstituted piperazines having dopaminergic activity (1989-10-17),
10. 4868184 - Benzhydrylpiperazines pharmaceutical compositions thereof and method of (1989-09-19),
11. 4866062 - 1,4-disubstituted piperazines, pharmaceutical compositions thereof and (1989-09-12),
12. 4859682 - 2-Halogenated-8- and 1,8-substituted ergolenes (1989-08-22),
13. 4843080 - 1,12-disubstituted octahydroindolo[2,3-]quinolizine derivatives, (1989-06-27),
14. 4806545 - (-)-1.beta.-ethyl-1.alpha.-hydroxymethyl-1,2,3,4,6,7,12, (1989-02-21),
15. 4753949 - 2-chloronicergoline having antihypoxic activity (1988-06-28),

Title: The Innovations of Istvan Laszlovszky

Introduction

Istvan Laszlovszky is a prominent inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dopamine receptor ligands. With a total of 17 patents to his name, his work has had a considerable impact on therapeutic applications.

Latest Patents

One of his latest patents involves (Thio) carbamoyl-cyclohexane derivatives as D3/D2 receptor antagonists. This invention relates to new D3 and D2 dopamine receptor subtype preferring ligands, which are crucial for modulating dopamine receptors. The patent outlines the chemical structure and potential therapeutic uses of these compounds. Another notable patent includes 2-methoxyphenylpiperazine derivatives, which further showcases his innovative approach to drug development.

Career Highlights

Throughout his career, Istvan has worked with notable companies such as Richter Gedeon Vegyeszeti Gyar Rt and Richter Gedeon Vegyeszeti Gyar Rt. His experience in these organizations has allowed him to refine his skills and contribute to various pharmaceutical advancements.

Collaborations

He has collaborated with esteemed colleagues, including Bela Kiss and Laszlo Szporny. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Istvan Laszlovszky's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…